
Tuesday, January 07, 2025 1:41:35 PM
A recently filed federal securities fraud class action complaint against Equinix, Inc. (NASDAQ: EQIX) and certain of its officers has survived Defendants’ attempt to dismiss the complaint. Grabar Law Office is investigating whether officers and directors of Equinix, Inc. have breached their fiduciary duties owed to the company.
If you have held Equinix shares since prior to May 3, 2019, and would like to learn more about the investigation, your rights, and your potential for recovery at no cost to you, please visit https://grabarlaw.com/the-latest/Equinix-Investigation/, contact Joshua Grabar at jgrabar @FH-6085. You do not need to have lost money on your investment.
WHY: A recently filed federal securities fraud class action complaint against Equinix and certain of its officers has survived Defendants’ attempt to dismiss the complaint. The underlying complaint alleges that Equinix, via certain of its officers and directors, made materially false and/or misleading statements and/or failed to disclose that: (1) Equinix manipulated its financials to reduce operational expenses and boost Adjusted Funds From Operations (“AFFO”); (2) Equinix oversold power capacity and did not warn of the risks associated with this practice; (3) Equinix lacked adequate internal controls; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.
In denying the Defendants’ motion to dismiss the Court found:
In all, the complaint raises a strong inference that Equinix misclassified routine recurring capital purchases—like chillers, batteries, and lightbulbs—as non-recurring to artificially inflate its AFFO numbers in a way that misled investors.
The Court further found that under a holistic view of the allegations, the complaint has created a strong inference of scienter – i.e. the intent or knowledge of wrongdoing, at the time of the alleged fraudulent activity.
WHAT YOU CAN DO NOW: Current Equinix shareholders who have held Equinix shares since on or before May 3, 2019, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them whatsoever.
If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/Equinix-Investigation/, contact Joshua Grabar at jgrabar @FH-6085.
$EQIX #Equinix
Attorney Advertising Disclaimer
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com
Recent EQIX News
- Equinix Sets Conference Call for Second-Quarter Results • PR Newswire (US) • 07/01/2025 12:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2025 09:30:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2025 08:28:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2025 08:14:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2025 08:13:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2025 08:12:28 PM
- Equinix to Host Analyst Day on June 25, 2025 • PR Newswire (US) • 06/03/2025 12:08:00 PM
- Equinix to Speak at Upcoming Investor Conference • PR Newswire (US) • 05/28/2025 12:01:00 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 05/13/2025 08:18:09 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 05/12/2025 08:34:52 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/12/2025 10:06:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2025 10:36:09 PM
- Hyundai Motor Group Delivers Enhanced In-Car Experience Through Equinix Data Centers Globally • PR Newswire (US) • 05/08/2025 12:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2025 08:26:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2025 08:12:12 PM
- Equinix Declares Quarterly Dividend on Its Common Stock • PR Newswire (US) • 04/30/2025 08:10:00 PM
- Equinix Reports First-Quarter 2025 Results • PR Newswire (US) • 04/30/2025 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2025 08:29:42 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/10/2025 08:17:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2025 08:06:26 PM
- Harmeen Mehta Joins Equinix as Chief Digital and Innovation Officer to Accelerate Customer and Employee Experiences • PR Newswire (US) • 04/03/2025 01:00:00 PM
- Equinix Sets Conference Call for First-Quarter Results • PR Newswire (US) • 04/01/2025 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2025 08:05:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2025 08:32:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2025 08:30:53 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM